Skip to main content

Select Drug Profiles

Cardiometabolic Health

Cardiovascular data confirm metformin over sulfonylurea as initial treatment choice in type 2 diabetes

Does insulin increase the risk of type 2 diabetes-related complications?

Anti-Inflammatory–Dose Doxycycline Is Equally Effective in Men and Women with Rosacea

Caroline Helwick

Genomic Testing and the Quality of Care: Exploring the Impact of Healthcare Reform

John Hornberger, MD, MS, William J. Gradishar, MD, FACP, Barry V. Fortner, PhD, Matthew R.G. Taylor, MD, PhD, Bryan Loy, MD

New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib-Based Therapy from ASH 2012

Lynne Lederman, PhD, R. Donald Harvey, PharmD, FCCP, BCOP, Beth Faiman, PhD(c), MSN, APRN-BC, AOCN, Atheer A. Kaddis, PharmD

Leukemia, Oncology

Initial Choice of TKI in Patients with CML Probably Not Important

Ponatinib: New Option for the Treatment of Adults with CML or Ph+ ALL that Is Resistant or Intolerant to Previous Therapy with Tyrosine Kinase Inhibitors

Lynne Lederman, PhD

New Data Presented at Highlight Challenges and Opportunities for Payers

Matthew Mitchell, PharmD, MBA, FAMCP

Multiple Myeloma, Oncology

Oral Proteasome Inhibitor MLN9708 a News Maker at ASH 2012

Caroline Helwick

Multiple Myeloma, Oncology

Four-Drug Induction and 2-Drug Maintenance Boost Overall Survival in Patients with Newly Diagnosed Myeloma

Page 182 of 244
Results 1811 - 1820 of 2438